{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:36:23Z","timestamp":1793457383408,"version":"4.5.0"},"reference-count":243,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["UL1 TR000135"],"award-info":[{"award-number":["UL1 TR000135"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007492","name":"Baylor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jhep.2018.09.014","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T22:11:54Z","timestamp":1537913514000},"page":"151-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3369,"title":["Burden of liver diseases in the world"],"prefix":"10.1016","volume":"70","author":[{"given":"Sumeet K.","family":"Asrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshad","family":"Devarbhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2018.09.014_b0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.jhep.2018.09.014_b0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1360-0443.1990.tb03074.x","article-title":"Liver cirrhosis with and without mention of alcohol as cause of death","volume":"85","author":"Haberman","year":"1990","journal-title":"Br J Addict"},{"key":"10.1016\/j.jhep.2018.09.014_b0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2013.04.005","article-title":"Underestimation of liver-related mortality in the United States","volume":"145","author":"Asrani","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0020","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(16)00648-6","article-title":"Global burden of diseases, injuries, and risk factors for young people's health during 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"387","author":"Mokdad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.09.014_b0025","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.07.056","article-title":"Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013","volume":"149","author":"Beste","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0030","doi-asserted-by":"crossref","first-page":"014","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.jhep.2018.09.014_b0035","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.09.014_b0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/CEJ.0b013e32833f0c8e","article-title":"Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia","volume":"20","author":"Dondog","year":"2011","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.jhep.2018.09.014_b0045","article-title":"Direct and indirect economic burden of chronic liver disease in the United States","author":"Stepanova","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0050","series-title":"Global health estimates 2015: deaths by cause, age, sex, by country and by region, 2000\u20132015","author":"WHO","year":"2016"},{"key":"10.1016\/j.jhep.2018.09.014_b0055","series-title":"Global health estimates 2015: disease burden by cause, age, sex, by country and by region, 2000-2015","author":"WHO","year":"2016"},{"key":"10.1016\/j.jhep.2018.09.014_b0060","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1053\/j.gastro.2015.08.045","article-title":"Burden of gastrointestinal, liver, and pancreatic diseases in the United States","volume":"149","author":"Peery","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0065","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","article-title":"Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders","volume":"373","author":"Rehm","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.09.014_b0070","series-title":"Global status report on alcohol 2004","author":"WHO","year":"2004"},{"key":"10.1016\/j.jhep.2018.09.014_b0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2013.03.007","article-title":"Global burden of alcoholic liver diseases","volume":"59","author":"Rehm","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0080","unstructured":"WHO. Global status report on alcohol and health 2014. 2014."},{"key":"10.1016\/j.jhep.2018.09.014_b0085","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jhep.2016.06.018","article-title":"Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide","volume":"65","author":"Stein","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.510250120","article-title":"Excess weight risk factor for alcoholic liver disease","volume":"25","author":"Naveau","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0100","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1365-2036.2012.05091.x","article-title":"Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study","volume":"35","author":"Deleuran","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.09.014_b0105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/jhep.2002.31782","article-title":"Risk factors of fibrosis in alcohol-induced liver disease","volume":"35","author":"Raynard","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0110","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1365-2036.2007.03302.x","article-title":"Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features","volume":"25","author":"Mathurin","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.09.014_b0115","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-230X-14-166","article-title":"Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease","volume":"14","author":"Haflidadottir","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0120","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"European Association for the Study of the L","year":"2016","journal-title":"Jurnal Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999\u20132010","volume":"307","author":"Flegal","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2018.09.014_b0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.28524","article-title":"The globalization of nonalcoholic fatty liver disease: prevalence and impact on world health","volume":"64","author":"Rinella","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0135","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults","volume":"390","author":"Collaboration NCDRF","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.09.014_b0140","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants","volume":"387","author":"Collaboration NCDRF","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.09.014_b0145","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2015.08.010","article-title":"Trends in the burden of nonalcoholic fatty liver disease in a united states cohort of veterans","volume":"14","author":"Kanwal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00535-015-1114-8","article-title":"Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery","volume":"51","author":"Seki","year":"2016","journal-title":"J Gastroenterolgy"},{"key":"10.1016\/j.jhep.2018.09.014_b0165","first-page":"2931985","article-title":"The burden of NAFLD and Its characteristics in a nationwide population with Type 2 diabetes","volume":"2016","author":"Forlani","year":"2016","journal-title":"J Diab Res"},{"key":"10.1016\/j.jhep.2018.09.014_b0170","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.09.014_b0175","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/ajg.2013.104","article-title":"Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study","volume":"108","author":"Xu","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00535-016-1264-3","article-title":"Nonalcoholic fatty liver disease in Asia: emerging perspectives","volume":"52","author":"Seto","year":"2017","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world","volume":"20","author":"Sayiner","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2018.09.014_b0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"178","author":"Lazo","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jhep.2018.09.014_b0195","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0210","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c1240","article-title":"Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies","volume":"340","author":"Hart","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2018.09.014_b0215","unstructured":"WHO. Global hepatitis report. 2017:1-83."},{"key":"10.1016\/j.jhep.2018.09.014_b0220","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.09.014_b0225","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013","volume":"388","author":"Stanaway","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.09.014_b0230","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4254\/wjh.v4.i3.68","article-title":"Hepatitis A: epidemiology and prevention in developing countries","volume":"4","author":"Franco","year":"2012","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0235","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1016\/j.vaccine.2010.08.037","article-title":"Hepatitis A virus seroprevalence by age and world region, 1990 and 2005","volume":"28","author":"Jacobsen","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jhep.2018.09.014_b0240","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/INF.0000000000001322","article-title":"Single-dose universal hepatitis A immunization in one-year-old children in Argentina: high prevalence of protective antibodies up to 9 years after vaccination","volume":"35","author":"Uruena","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jhep.2018.09.014_b0245","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/INF.0000000000000042","article-title":"Impact of the single-dose immunization strategy against hepatitis A in Argentina","volume":"33","author":"Vizzotti","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jhep.2018.09.014_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2893.2000.00021.x","article-title":"What did we learn from the Shanghai hepatitis A epidemic?","volume":"7","author":"Cooksley","year":"2000","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2018.09.014_b0255","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2017.08.034","article-title":"Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention","volume":"68","author":"Lemon","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0260","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.09.014_b0265","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0270","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"EASL","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0275","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.patbio.2009.11.002","article-title":"Hepatitis B vaccination in children: the Taiwan experience","volume":"58","author":"Ni","year":"2010","journal-title":"Pathol Biol"},{"key":"10.1016\/j.jhep.2018.09.014_b0280","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1473-3099(16)30325-5","article-title":"Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013","volume":"16","author":"Degenhardt","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2018.09.014_b0285","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jhep.2018.01.031","article-title":"Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population","volume":"68","author":"Papatheodoridis","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0290","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/hep.29320","article-title":"The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B","volume":"66","author":"Papatheodoridis","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0295","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0168-8278(18)30395-7","article-title":"PS-159 - Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: results from the DARING-B prospective Greek study","volume":"68","author":"Papatheodoridis","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0300","unstructured":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2017;2:161\u2013176."},{"key":"10.1016\/j.jhep.2018.09.014_b0305","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2334-13-181","article-title":"Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening","volume":"13","author":"Hahne","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhep.2018.09.014_b0310","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2018.09.014_b0315","doi-asserted-by":"crossref","first-page":"174","DOI":"10.35946\/arcr.v35.2.07","article-title":"Global alcohol-attributable deaths from cancer, liver cirrhosis, and injury in 2010","volume":"35","author":"Rehm","year":"2013","journal-title":"Alcohol Res: Curr Rev"},{"key":"10.1016\/j.jhep.2018.09.014_b0320","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12879-018-2988-x","article-title":"Hepatitis B\/C in the countries of the EU\/EEA: a systematic review of the prevalence among at-risk groups","volume":"18","author":"Falla","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhep.2018.09.014_b0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103345","article-title":"Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention","volume":"9","author":"Wiessing","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhep.2018.09.014_b0330","unstructured":"www.who.int\/mediacentre\/factsheets\/fs164\/en."},{"key":"10.1016\/j.jhep.2018.09.014_b0335","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.12.032","article-title":"Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection","volume":"140","author":"Kanwal","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0340","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jvh.12248","article-title":"The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm","volume":"1","author":"Razavi","year":"2014","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2018.09.014_b0345","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(10)61931-9","article-title":"Hepatitis delta virus","volume":"378","author":"Hughes","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.09.014_b0350","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1478-3231.2010.02320.x","article-title":"Hepatitis D virus: an update","volume":"31","author":"Pascarella","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.09.014_b0355","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/hep.28957","article-title":"A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians","volume":"66","author":"Chen","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0360","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000444467","article-title":"Chronic Hepatitis D; at a standstill?","volume":"34","author":"Rizzetto","year":"2016","journal-title":"Dig Dis (Basel, Switzerland)"},{"key":"10.1016\/j.jhep.2018.09.014_b0365","doi-asserted-by":"crossref","DOI":"10.1002\/hep.21590","article-title":"Hepatitis D virus infection--not a vanishing disease in Europe!","volume":"45","author":"Wedemeyer","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0370","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005","volume":"55","author":"Rein","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0375","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","article-title":"EASL Clinical Practice Guidelines on hepatitis E virus infection","volume":"68","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0380","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3201\/eid2212.160979","article-title":"New Hepatitis E virus genotype in bactrian camels, Xinjiang, China, 2013","volume":"22","author":"Woo","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jhep.2018.09.014_b0385","article-title":"Chronic infection with camelid Hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0390","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.22493","article-title":"A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse?","volume":"48","author":"Bhatia","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0395","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","article-title":"Hepatitis E","volume":"379","author":"Kamar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.09.014_b0400","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jhep.2016.02.045","article-title":"Update on hepatitis E virology: implications for clinical practice","volume":"65","author":"Debing","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0405","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/apt.13309","article-title":"Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK\/French study","volume":"42","author":"Blasco-Perrin","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.09.014_b0410","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0415","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0420","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0425","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis \u2013 a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0430","article-title":"Characteristics and outcomes reported by patients with primary sclerosing cholangitis through an online registry","author":"Kuo","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0435","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0440","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0445","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0450","doi-asserted-by":"crossref","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","article-title":"Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Valle","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2018.09.014_b0455","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bpg.2015.02.003","article-title":"Epidemiology of cholangiocarcinoma","volume":"29","author":"Bergquist","year":"2015","journal-title":"Best Prac Res Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhep.2018.09.014_b0460","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0465","first-page":"837","article-title":"Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis","volume":"22","author":"Ren","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jhep.2018.09.014_b0470","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12957-015-0583-9","article-title":"Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies","volume":"13","author":"Li","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.jhep.2018.09.014_b0475","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1471-2407-12-289","article-title":"Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis","volume":"12","author":"Zhou","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jhep.2018.09.014_b0480","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1349-7006.2009.01458.x","article-title":"Epidemiology of cholangiocarcinoma: an update focusing on risk factors","volume":"101","author":"Shin","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jhep.2018.09.014_b0485","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0490","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.cgh.2015.05.035","article-title":"Primary sclerosing cholangitis as a premalignant biliary tract disease: surveillance and management","volume":"13","author":"Rizvi","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0495","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOG.0b013e3282fbf9b3","article-title":"Cholangiocarcinoma: lessons from Thailand","volume":"24","author":"Sripa","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0500","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0505","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2011.11.015","article-title":"Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?","volume":"56","author":"Khan","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0510","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jnci\/djj234","article-title":"Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States","volume":"98","author":"Welzel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2018.09.014_b0515","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2011.11.015","article-title":"Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?","volume":"56","author":"Khan","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0520","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000449493","article-title":"Current status on cholangiocarcinoma and gallbladder cancer","volume":"6","author":"Ebata","year":"2016","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jhep.2018.09.014_b0525","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","article-title":"Changing international trends in mortality rates for liver, biliary and pancreatic tumours","volume":"37","author":"Khan","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0530","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0535","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ajg.2012.173","article-title":"Biliary tract cancers in Olmsted County, Minnesota, 1976\u20132008","volume":"107","author":"Yang","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0540","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/ijc.30211","article-title":"International trends in liver cancer incidence, overall and by histologic subtype, 1978\u20132007","volume":"139","author":"Petrick","year":"2016","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.jhep.2018.09.014_b0545","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist."},{"issue":"2","key":"10.1016\/j.jhep.2018.09.014_b0550","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2004-828889","article-title":"The epidemiology of cholangiocarcinoma","volume":"24","author":"Shaib","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2018.09.014_b0555","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/ijc.30211","article-title":"International trends in liver cancer incidence, overall and by histologic subtype, 1978\u20132007","volume":"139","author":"Petrick","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhep.2018.09.014_b0560","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MEG.0b013e328353753d","article-title":"The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study","volume":"24","author":"Baldursdottir","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0565","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0570","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0575","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.26365","article-title":"Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study","volume":"58","author":"Mells","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0580","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0585","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/liv.12434","article-title":"Rising incidence and prevalence of primary biliary cirrhosis: a large population-based study","volume":"34","author":"Boonstra","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.09.014_b0590","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0595","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0600","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2013.04.017","article-title":"The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study","volume":"59","author":"Carbone","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0605","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.005","article-title":"Cutting edge issues in autoimmune hepatitis","volume":"75","author":"Liberal","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2018.09.014_b0610","first-page":"1022","article-title":"Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis","volume":"52","author":"Danielsson Borssen","year":"2017","journal-title":"Scandinavian J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0615","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3109\/00365521.2014.946083","article-title":"Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands","volume":"49","author":"van Gerven","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0620","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gronbaek","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0625","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s12072-016-9767-9","article-title":"Autoimmune liver diseases in the Asia-Pacific region: proceedings of APASL symposium on AIH and PBC 2016","volume":"10","author":"Tanaka","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2018.09.014_b0630","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2018.09.014_b0635","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0640","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/ahg.12024","article-title":"Wilson disease mutation pattern with genotype-phenotype correlations from Western India: confirmation of p.C271* as a common Indian mutation and identification of 14 novel mutations","volume":"77","author":"Aggarwal","year":"2013","journal-title":"Ann Human Genetics"},{"key":"10.1016\/j.jhep.2018.09.014_b0645","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","article-title":"EASL Clinical Practice Guidelines: Wilson's disease","volume":"56","author":"European Association for Study of L","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0650","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/brain\/awt035","article-title":"A genetic study of Wilson's disease in the United Kingdom","volume":"136","author":"Coffey","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.jhep.2018.09.014_b0655","first-page":"016","article-title":"Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature","volume":"14","author":"Onakpoya","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.jhep.2018.09.014_b0660","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0665","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bjornsson","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0670","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.meg.0000250581.77865.68","article-title":"Antibiotic therapy: a major cause of drug-induced jaundice in southwest England","volume":"19","author":"Hussaini","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0675","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.2004.02133.x","article-title":"Acute and clinically relevant drug-induced liver injury: a population-based case-control study","volume":"58","author":"de Abajo","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jhep.2018.09.014_b0680","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00228-004-0888-z","article-title":"Incidence of drug-induced liver injury in medical inpatients","volume":"61","author":"Meier","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.jhep.2018.09.014_b0685","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","article-title":"Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic","volume":"24","author":"De Valle","year":"2006","journal-title":"Alimentary Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.09.014_b0690","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1038\/ajg.2010.287","article-title":"Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality","volume":"105","author":"Devarbhavi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0695","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.28323","article-title":"Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports","volume":"63","author":"Bjornsson","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0700","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-0034-1375956","article-title":"Drug-induced liver injury due to antimicrobials, central nervous system agents, and nonsteroidal anti-inflammatory drugs","volume":"34","author":"Devarbhavi","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2018.09.014_b0705","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/j.1875-9114.1997.tb03747.x","article-title":"A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom","volume":"17","author":"Garcia Rodriguez","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jhep.2018.09.014_b0710","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0715","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ajg.2012.138","article-title":"A prospective nationwide study of drug-induced liver injury in Korea","volume":"107","author":"Suk","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0720","unstructured":"WHO. Global Tuberculosis Report. 2017."},{"key":"10.1016\/j.jhep.2018.09.014_b0725","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/MEG.0b013e32835f6889","article-title":"Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients","volume":"25","author":"Zhou","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0730","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.27317","article-title":"Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network","volume":"60","author":"Navarro","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0735","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1053\/j.gastro.2014.12.004","article-title":"Herbal products and the liver: a review of adverse effects and mechanisms","volume":"148","author":"Seeff","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0740","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/lt.21119","article-title":"Acute liver failure in Spain: analysis of 267 cases","volume":"13","author":"Escorsell","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.09.014_b0745","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/j.1572-0241.2007.01388.x","article-title":"Population-based surveillance for acute liver failure","volume":"102","author":"Bower","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"26","key":"10.1016\/j.jhep.2018.09.014_b0750","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1056\/NEJMra1208937","article-title":"Acute liver failure","volume":"369","author":"Bernal","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jhep.2018.09.014_b0755","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/M15-2211","article-title":"Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study","volume":"164","author":"Reuben","year":"2016","journal-title":"Ann Internal Med"},{"key":"10.1016\/j.jhep.2018.09.014_b0760","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jhep.2013.02.010","article-title":"Lessons from look-back in acute liver failure? A single centre experience of 3300 patients","volume":"59","author":"Bernal","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0765","first-page":"13662","article-title":"Drug-induced acute liver failure in children and adults: results of a single-centre study of 128 patients","volume":"9","author":"Devarbhavi","year":"2017","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jhep.2018.09.014_b0770","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11901-017-0367-5","article-title":"Acute liver failure induced by anti-infectious drugs: causes and management","volume":"16","author":"Devarbhavi","year":"2017","journal-title":"Curr Hepatol Rep"},{"key":"10.1016\/j.jhep.2018.09.014_b0775","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/liv.13535","article-title":"Acute liver failure induced by idiosyncratic reaction to drugs: challenges in diagnosis and therapy","volume":"38","author":"Tujios","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.09.014_b0780","article-title":"Causes and outcomes of acute liver failure in China","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhep.2018.09.014_b0785","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jpeds.2005.12.051","article-title":"Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group","volume":"148","author":"Squires","year":"2006","journal-title":"J Pediatrics"},{"key":"10.1016\/j.jhep.2018.09.014_b0790","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1007\/s10620-017-4461-x","article-title":"Acute liver failure due to Hepatitis E virus infection is associated with better survival than other etiologies in Indian patients","volume":"62","author":"Shalimar","year":"2017","journal-title":"Digest Dis Sci"},{"key":"10.1016\/j.jhep.2018.09.014_b0795","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1478-3231.2011.02517.x","article-title":"All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study","volume":"32","author":"Fleming","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.09.014_b0800","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0805","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","author":"D'Amico","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0810","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/ajg.2015.191","article-title":"Causes of death in people with liver cirrhosis in England compared with the general population: a population-based cohort study","volume":"110","author":"Ratib","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0815","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D'Amico","year":"2014","journal-title":"Alimentary Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.09.014_b0820","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1365-2036.2010.04473.x","article-title":"The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study","volume":"32","author":"Fleming","year":"2010","journal-title":"Alimentary Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.09.014_b0825","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.09.014_b0830","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.09.014_b0835","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0168-8278(02)00420-8","article-title":"Incidence and natural history of small esophageal varices in cirrhotic patients","volume":"38","author":"Merli","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0840","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural history of patients hospitalized for management of cirrhotic ascites","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0845","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study","volume":"51","author":"Jepsen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0850","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0855","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2011.10.016","article-title":"Renal failure and cirrhosis: a systematic review of mortality and prognosis","volume":"56","author":"Fede","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b0860","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187033","article-title":"Etiology and mode of presentation of chronic liver diseases in India: a multi centric study","volume":"12","author":"Mukherjee","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhep.2018.09.014_b0865","doi-asserted-by":"crossref","DOI":"10.1136\/jim-2018-000709","article-title":"Development of a novel clinical staging model for cirrhosis using the Nationwide Inpatient Sample","author":"Haj","year":"2018","journal-title":"J Investig Med"},{"key":"10.1016\/j.jhep.2018.09.014_b0870","article-title":"Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study","volume":"64","author":"Asrani","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0875","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-0036-1583201","article-title":"Epidemiology and healthcare burden of acute-on-chronic liver failure","volume":"36","author":"Allen","year":"2016","journal-title":"Seminars Liver Dis"},{"key":"10.1016\/j.jhep.2018.09.014_b0880","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/MCG.0000000000000538","article-title":"Population-representative incidence of acute-on-chronic liver failure: a prospective cross-sectional study","volume":"50","author":"Qin","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0885","doi-asserted-by":"crossref","first-page":"9205","DOI":"10.3748\/wjg.v22.i41.9205","article-title":"Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis","volume":"22","author":"Kim","year":"2016","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.jhep.2018.09.014_b0890","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0895","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.27077","article-title":"Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures","volume":"60","author":"Bajaj","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0900","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3109\/00365521.2015.1017834","article-title":"Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure","volume":"50","author":"Sargenti","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b0905","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.27795","article-title":"Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults","volume":"62","author":"Shi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0910","article-title":"Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to Hepatitis B","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2018.09.014_b0915","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0920","article-title":"Characteristics and discrepancies in acute-on-chronic liver failure: need for a unified definition","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhep.2018.09.014_b0925","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/hep.28812","article-title":"Time trends in the health care burden and mortality of acute on chronic liver failure in the United States","volume":"64","author":"Allen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0930","article-title":"Comparison of current diagnostic criteria for acute-on-chronic liver failure","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhep.2018.09.014_b0935","doi-asserted-by":"crossref","unstructured":"S. Piano V. Singh P. Caraceni R. Maiwall C. Alessandria J. Fernandez et al. Epidemiology, predictors and outcomes of multi drug resistant bacterial infections in patients with cirrhosis across the world. Final results of the \u201cGlobal study\u201d J Hepatol 2018 68 S1","DOI":"10.1016\/S0168-8278(18)30220-4"},{"key":"10.1016\/j.jhep.2018.09.014_b0940","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study","author":"Fitzmaurice","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhep.2018.09.014_b0945","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1600-6143.2005.00769.x","article-title":"The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution","volume":"5","author":"Brown","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2018.09.014_b0950","unstructured":"1973-2015 SRD. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2015). National Cancer Institute, DCCPS, Surveillance Research Program released April 2018, based on the November 2017 submission."},{"key":"10.1016\/j.jhep.2018.09.014_b0955","unstructured":"Ferlay J SI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. 2013; http:\/\/globocan.iarc.fr. Accessed 1\/2\/2017, 2017."},{"key":"10.1016\/j.jhep.2018.09.014_b0960","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cld.2015.01.001","article-title":"Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability","volume":"19","author":"McGlynn","year":"2015","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2018.09.014_b0965","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b0970","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.amjmed.2008.03.005","article-title":"Racial and ethnic variations in hepatocellular carcinoma incidence within the United States","volume":"121","author":"Wong","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2018.09.014_b0975","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.26986","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S","volume":"59","author":"Wong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0980","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.27969","article-title":"World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma","volume":"62","author":"de Martel","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b0985","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/cncr.30246","article-title":"Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States","volume":"123","author":"Yang","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2018.09.014_b0990","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jnci\/djn243","article-title":"Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma","volume":"100","author":"Yang","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2018.09.014_b0995","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/gast.2003.50053","article-title":"Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers","volume":"124","author":"Kao","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b1000","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2018.09.014_b1005","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jhep.2009.01.019","article-title":"Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis","volume":"50","author":"Raimondi","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b1010","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1586\/17474124.2015.1028363","article-title":"The evolving epidemiology of hepatocellular carcinoma: a global perspective","volume":"9","author":"Wallace","year":"2015","journal-title":"Exp Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b1015","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/ajcn\/80.5.1106","article-title":"Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions","volume":"80","author":"Williams","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jhep.2018.09.014_b1020","first-page":"2058","article-title":"Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530","volume":"32","author":"Garner","year":"1972","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2018.09.014_b1025","first-page":"3","article-title":"A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China","volume":"3","author":"Qian","year":"1994","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"key":"10.1016\/j.jhep.2018.09.014_b1030","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1289\/ehp.0901388","article-title":"Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment","volume":"118","author":"Liu","year":"2010","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jhep.2018.09.014_b1035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006086","article-title":"Genome-wide mutational signatures of aristolochic acid and its application as a screening tool","volume":"5","author":"Poon","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2018.09.014_b1040","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1054\/bjoc.1999.1597","article-title":"Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study","volume":"84","author":"Tsai","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhep.2018.09.014_b1045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.md.0000126971.80227.a4","article-title":"Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis","volume":"83","author":"Tsai","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.jhep.2018.09.014_b1050","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1053\/j.gastro.2004.09.020","article-title":"Alcohol and hepatocellular carcinoma","volume":"127","author":"Morgan","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.09.014_b1055","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1542-3565(05)00407-6","article-title":"Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis","volume":"3","author":"Hutchinson","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b1060","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/jnci\/djh334","article-title":"Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea","volume":"96","author":"Jee","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2018.09.014_b1065","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jhep.2012.11.045","article-title":"Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis","volume":"58","author":"Lin","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b1070","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?","volume":"60","author":"El-Serag","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b1075","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/ajg.2013.160","article-title":"Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States","volume":"108","author":"Welzel","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.09.014_b1080","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/jnci\/djr395","article-title":"Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study","volume":"103","author":"Trichopoulos","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2018.09.014_b1085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"Dyson","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b1090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S2213-8587(17)30366-2","article-title":"Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment","volume":"6","author":"Pearson-Stuttard","year":"2018","journal-title":"Lancet Diab Endocrinol"},{"key":"10.1016\/j.jhep.2018.09.014_b1095","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cncr.29936","article-title":"Annual report to the nation on the status of cancer, 1975\u20132012, featuring the increasing incidence of liver cancer","volume":"122","author":"Ryerson","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2018.09.014_b1100","unstructured":"Ferlay JSI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. Incidence\/mortality data. 2018."},{"key":"10.1016\/j.jhep.2018.09.014_b1105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev.publhealth.29.020907.090859","article-title":"Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries","volume":"29","author":"Groopman","year":"2008","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.jhep.2018.09.014_b1110","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cld.2016.06.006","article-title":"Epidemiology of Hepatitis B virus infection and impact of vaccination on disease","volume":"20","author":"Nelson","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2018.09.014_b1115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hep.27048","article-title":"Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees","volume":"60","author":"Chien","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b1120","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.26301","article-title":"Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis","volume":"58","author":"Wong","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.09.014_b1125","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cgh.2013.09.062","article-title":"Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population","volume":"12","author":"Gordon","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b1130","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdw219","article-title":"The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma","volume":"27","author":"Wirth","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2018.09.014_b1135","unstructured":"www.transplant-observatory.org. Global Observatory on Donation and Transplantation. 2015."},{"key":"10.1016\/j.jhep.2018.09.014_b1140","unstructured":"www.transplant-observatory.org\/organ-donation-transplantation-activities-2015-report-2."},{"key":"10.1016\/j.jhep.2018.09.014_b1145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/ajt.14126","article-title":"OPTN\/SRTR 2015 annual data report: liver","volume":"1","author":"Kim","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2018.09.014_b1150","unstructured":"www.edqm.eu\/en\/organ-transplantation-reports-73.html."},{"key":"10.1016\/j.jhep.2018.09.014_b1155","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/lt.24508","article-title":"Liver transplantation around the world","volume":"22","author":"Trotter","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.09.014_b1160","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/lt.24502","article-title":"Liver transplantation in Japan","volume":"22","author":"Soyama","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.09.014_b1165","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/lt.24461","article-title":"Liver transplantation in Germany","volume":"22","author":"Tacke","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.09.014_b1170","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/lt.24462","article-title":"Liver transplantation in the United Kingdom","volume":"22","author":"Neuberger","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.09.014_b1175","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/lt.24459","article-title":"Liver transplantation in India","volume":"22","author":"Narasimhan","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.09.014_b1180","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/lt.24456","article-title":"Liver transplantation in Ireland","volume":"22","author":"Iqbal","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.09.014_b1185","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/lt.24446","article-title":"Liver transplantation in Australia and New Zealand","volume":"22","author":"McCaughan","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.09.014_b1190","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.24487","article-title":"Liver transplantation in Brazil","volume":"22","author":"Bittencourt","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.09.014_b1195","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/lt.24484","article-title":"Liver transplantation in Spain","volume":"22","author":"de la Rosa","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.09.014_b1200","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nrgastro.2013.194","article-title":"Why does living donor liver transplantation flourish in Asia?","volume":"10","author":"Chen","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.09.014_b1205","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.transproceed.2015.02.015","article-title":"Liver transplantation in Korea: past, present, and future","volume":"47","author":"Lee","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2018.09.014_b1210","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-014-0131-4","article-title":"An international comparison of deceased and living organ donation\/transplant rates in opt-in and opt-out systems: a panel study","volume":"12","author":"Shepherd","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.jhep.2018.09.014_b1215","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/ajt.14104","article-title":"How Spain reached 40 deceased organ donors per million population","volume":"17","author":"Matesanz","year":"2017","journal-title":"Am J Transplant"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818323882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818323882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:34:57Z","timestamp":1759174497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827818323882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":243,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0168827818323882"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2018.09.014","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burden of liver diseases in the world","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2018.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}